Fig. 4From: Engineered extracellular vesicles: potentials in cancer combination therapyEngineered EVs for the combination of chemotherapy with anti-drug resistance treatment. Mono-chemotherapy often induces multi-drug resistance (MDR) in cancer cells. Engineered EVs as delivery platforms can realize co-delivery of anti-MDR substances like P-glycoprotein (P-gp) siRNA and chemotherapeutic drugs to suppress MDR and improve the chemotherapeutic effectsBack to article page